Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Topical minoxidil is the primary treatment for female pattern hair loss in India.

PSA can help diagnose high androgen levels in women.

Treating prolactinoma doesn't significantly affect hirsutism or cause high androgen levels.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Lophocereus marginatus extracts may help treat melanoma and stimulate hair growth.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

New treatments like low-level laser therapy, platelet-rich plasma therapy, and micro needling show positive results for hair regrowth in people with genetic hair loss.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Finasteride effectively treats male pattern baldness.

Non-drug treatments improved hair growth and reduced hair loss in androgenetic alopecia.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Hidradenitis suppurativa improves with antiandrogen therapy.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.